Zurich
Overview
Cipla
Manufacturing · India · 25,000 Employees
Founded in 1935, Cipla is a global pharmaceutical company that primarily develops medicines to treat respiratory, cardiovascular disease, arthritis, diabetes.
Cipla conferred the ‘1st Institute of Company Secretaries of India Business Responsibility and Sustainability Award’ for inculcating business responsibility and adopting leading sustainability practices.
In addition, Cipla also received the ‘Certificate of Recognition’ for excellence in Corporate Governance by the Institute of Company Secretaries of India (ICSI).
Overview
Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For over 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries. Our portfolio includes over 1000 products across wide range of therapeutic categories with one quality standard globally. Whilst delivering a long-term sustainable business, Cipla recognises its duty to provide affordable medicines. Cipla’s emphasis on access for patients was recognised globally for the pioneering role played in HIV/AIDS treatment as the first pharmaceutical company to provide a triple combination anti-retroviral (ARV) in Africa at less than a dollar a day and thereby treating many millions of patients since 2001. Cipla’s research and development focuses on developing innovative products and drug delivery systems.
- Website http://www.cipla.com
- Industry Pharmaceutical Manufacturing
- Company size 10,001+ employees
- Headquarters Mumbai, Maharashtra
- Founded 1935
- Specialties Pharmaceuticals and Active Pharmaceutical Ingredients
-
STANDING STRONG. CARING FOR LIFE.
The Company through the Foundation continues its passionate journey of social change through collaborations. We endeavour to empower vulnerable communities and keep them at the heart of all our CSR initiatives.
C(A)RE – Accelerating Community Well-being
At Cipla, we believe that businesses can grow sustainably only in an ecosystem of interdependence with society. Our endeavour has always been to build an inclusive society and work collaboratively to achieve positive societal change.
Our focus areas for accelerating community well-being include
Health | Skilling | Education | Disaster ResponseOur purpose of CaringforLife extends to our people and the planet. We constantly strive to create a sustainable future and towards this, we have articulated our ESG positioning as ‘CARE’.
C: Championing Climate Positivity
A: Accelerating Community Well-being
R: Raising the Bar on Governance
E: Enhancing Access and AffordabilityCipla awarded the Golden Peacock Award for Excellence in Corporate Governance for 2022
Cipla Health bags 3 Gold & 2 Silver at the e4m Mobile Marketing Awards – The Maddies 2022
Nicotex – Quitting is winning with Nico campaign
– (Gold) AI & Machine Learning and Most Effective Chatbot Solution category
– (Silver) Programmatic Learning categoryOmnigel – Omnigel Dard ko jad se mitaye
– (Gold) Best Use Of Mobile – Property categoryCofsils – Cofsils use of Temperature API
– (Silver) Maximizing Mobile Advertising category
At Cipla, we constantly work towards ensuring access to high quality and affordable medicines to support patients in need. Which is why, we have been trusted by health care professionals and patients across geographies for the last 8 decades.
Cipla has been recognized yet again for its sustainability endeavours. BW Businessworld has featured Cipla amongst the Top 40 BW Most Sustainable Companies in India.
Dr. Y. K. Hamied
Non-Executive ChairmanDr Y.K. Hamied is Non-Executive Chairman of the Company, and represents the second generation of Cipla’s founding family. A world-renowned scientist, Dr Hamied obtained his PhD in organic chemistry in 1960 from the University of Cambridge under the tutelage of the Nobel laureate Lord Alexander Todd.
Mr. M. K. Hamied
Non-Executive Vice-ChairmanMr. M. K. Hamied is a science graduate from Bombay University and has vast and varied experience in all functions of the Company including production, technical areas, quality management and general administration.He is Non-Executive Vice-Chairman of the Company and represents the second generation of Cipla’s founding family.
Ms. Samina Hamied
Executive Vice-ChairpersonMs Samina Hamied is the Executive Vice-Chairperson of the Company, and represents the third generation of Cipla’s founding family. Samina is a MSc in International Accounting and Finance from the London School of Economics and Political Science. An alumna of the London School of Economics, she has in the past worked in UK and the US with the leading global firm.
Mr. Umang Vohra
Managing Director & Global Chief Executive OfficerUmang Vohra is Managing Director and Global Chief Executive Officer (MD and GCEO) of Cipla since September 2016. Umang joined Cipla in October 2015 as its Global Chief Financial Officer, and from January 2016 to August 2016 was Cipla’s Global Chief Operating Officer.
Mr. S. Radhakrishnan
Non-Executive DirectorMr S. Radhakrishnan is a Non-Executive Director of the Company and is a qualified Chartered Accountant. He possesses rich experience in financial, commercial, legal and allied areas.
Mr. Ashok Sinha
Independent DirectorMr Ashok Sinha is an Independent Non-Executive Director of the Company. He has a B.Tech. degree in Electrical Engineering from the Indian Institute of Technology (IIT), Kanpur and Post Graduate Diploma in Management from the Indian Institute of Management (IIM), Bangalore with specialisation in Finance.
Mr. Adil Zainulbhai
Independent DirectorMr Adil Zainulbhai is an Independent Non-Executive Director and Lead Independent Director of the Company. He is the Chairman of the Quality Council of India (QCI) and Board Advisor to US India strategic partnership forum.
Dr. Peter Mugyenyi
Independent DirectorDr Peter Mugyenyi is an Independent Non-Executive Director of the Company. He is a Bachelor of Medicine and Surgery (MB ChB), Fellow of the Royal College of Physicians of Ireland (FRCPI), Fellow of the Royal College of Physicians (Edinburgh) (FRCP Edin), Doctor of Science [ScD(h)], is a Ugandan Paediatrician, researcher and specialist on HIV/AIDS and related conditions.
Mr. P. R. Ramesh
Independent DirectorMr P. R. Ramesh graduated in Commerce from Osmania University, Hyderabad and is a Fellow Member of the ICAI. He retired as the Director of Deloitte & Touche Assurance & Enterprise Risk Services India on 31st March 2020 and has also served as a member of Deloitte Global Board and Deloitte Asia Pacific Board.
Ms. Punita Lal
Independent DirectorMs Punita Lal is an Independent Non-Executive Director of the Company. She is a B.A. (Hons.) Economics graduate from St. Stephen’s College, Delhi and an MBA from Indian Institute of Management, Kolkata.
Mr. Robert Stewart
Independent DirectorRobert Stewart is an Independent Non-Executive Director of the Company. He has over 34 years of experience in the biopharmaceutical industry having worked with leading companies such as Roche, Abbott, Watson / Actavis / Allergan, Amneal and Theramex. Currently, Robert is the Chief Executive Officer at Theramex Ltd, a global specialty pharmaceutical company.
Dr. Mandar Vaidya
Independent DirectorDr. Mandar is a medical doctor, and a management graduate from the Jamnalal Bajaj Institute of Management Studies, India.
Europe
Cipla Europe offers a range of therapies including Respiratory, HIV, OTC, Anti-Infectives and Hospital products. We have our presence directly in Germany, Norway, Spain and the UK. In rest of Europe, we largely work through our channel and licensed partners. We have 60+ employees across Europe. Our European business today contributes about 4% to the overall company revenue.
Quick Facts
Incorporated
1935
Employees
25,000+
Turnover
USD 2.92 Billion
Founder (1898-1972)
Dr. K.A. Hamied
Chairman
Dr. Y.K. Hamied
Vice-Chairman
Mr. M.K. Hamied
Manufacturing highlights
Our investments in manufacturing capital include development of new drug delivery systems, facilitation of infrastructure supporting API and formulation developments and strengthening of platform technologies.
2019
Cipla is a global pharmaceutical company
high quality
affordable medicine and support
Map
Video
Visited 63 times, 2 Visits today